Sector News

AB InBev’s volumes fall 9.3% in Q1, expects bigger Q2 hit

May 7, 2020
Food & Drink

AB InBev has reported that its global volume sales declined 9.3% in its first-quarter results, however April figures suggest that Covid-19 impact will be greater in its second quarter.

Growth of AB InBev’s three global brands – Budweiser, Stella Artois and Corona – across the majority of its markets was more than offset by declines in China, which is the largest market for both Budweiser and Corona outside of their home markets.

Excluding China, volumes declined by 3.6%, despite initial growth of 1.9% in January and February. The firm said that the impact of Covid-19 on its results increased significantly towards the end of the quarter due to shortfall from lost sales from bars and restaurants.

However, the Belgium-based company expects a “materially worse” second quarter, as its April global volumes already witnessed a decline of approximately 32% due to the closure of the on-premise channel in most markets.

The world’s largest brewer recorded a 5.8% drop in revenue to $11 billion compared to last year’s $12.2 billion. Meanwhile, gross operating profit (EBITDA) was worse than the company predicted in its last quarter and fell 13.7% to $3.95 billion.

In the US, the firm’s largest market, revenue grew by 1.9% driven by its top 10 brands and above core portfolio. However, overall market share was lost as the trend for hard seltzer’s accelerated but the company is pushing more into this category with the entry of Bud Light Seltzer.

In the US, Canada and Western Europe, AB InBev has benefitted from an increase in retail sales as the off-premise channel represents the majority of the firm’s sales. Meanwhile, in Brazil and Colombia, the brewer witnessed significant impact to its volumes due to the relevance of the on-premise channel which is predominantly closed.

In markets such as Mexico, South Africa and Peru, brewery operations have been severely restricted however the company’s Corona brand led the way with growth.

AB InBev’s China market has been showing improvements with volumes declining approximately 17% in April compared to a decline of 46.5% in its first quarter.

The firm said they will best practices from its experiences in China and South Korea – which are showing early signs of recovery – to the rest of its markets, as restaurants and bars began re-opening from mid-March.

The company’s first-quarter results coincide with the Foreign Investment Review Board’s approval of Asahi’s acquisition of AB InBev’s Australian subsidiary Carlton and United Breweries (CUB). This marks the closing of the regulatory review process and enables the completion of the transaction to go forward on 1 June.

By: Emma Upshell

Source: Food Ingredients First

comments closed

Related News

November 27, 2022

Cargill to appoint Brian Sikes as president and CEO

Food & Drink

Cargill will appoint Brian Sikes as its president and chief executive officer on 1 January 2023. The soon-to-be CEO, currently holding the chief operating officer title, has worked at Cargill for 31 years. Dave MacLennan, who has served as Cargill’s CEO since 2013, will assume the role of executive chair of the company’s board of directors.

November 27, 2022

Wellness, self-expression drive the latest trends in colors and flavors

Food & Drink

Comforting colors, feel-good flavors, and unique food and beverage experiences will resonate most with consumers in the new year, according to ADM’s latest Flavor and Color Outlook. ADM anticipates that 2023 will be the year of self-expression, and the company identified four trends that are sure to stand out.

November 27, 2022

Nespresso unveils home-compostable coffee capsules in partnership with Huhtamaki

Food & Drink

Nestlé’s Nespresso brand will pilot home-compostable coffee capsules on the Nespresso Original system in France and Switzerland from spring 2023 before further launches in several other European countries within a year. The paper-based capsules are touted as a breakthrough in packaging technology after three years of R&D.